Centre d'Oncologie et de Radiothérapie 37

What Centre d'Oncologie et de Radiothérapie 37 does

CORT 37 (Société Centre d'Oncologie et de Radiothérapie 37 SESARL) is a privately-held, physician-owned radiotherapy and oncology center operating from a single site at the Pôle Santé Léonard de Vinci health campus in Chambray-lès-Tours, France. The center serves cancer patients across the Indre-et-Loire department of the Centre-Val de Loire region, treating more than 1,000 patients and delivering roughly 26,000 radiotherapy sessions per year. Its clinical services span external beam radiotherapy, intensity-modulated and image-guided radiotherapy (IMRT/IGRT), stereotactic radiotherapy, contact therapy (Papillon+), high-dose-rate brachytherapy (Saginova Bebig), and chemotherapy.

The technology base relies on a fleet of advanced medical devices: Varian Halcyon Hypersight and Varian Truebeam linear accelerators, the Papillon+ contact therapy system, a Saginova HDR brachytherapy unit, and a Siemens Somatom Go.sim CT simulator used for treatment planning. Supportive care is delivered via photobiomodulation devices (THOR, CAREMIN 650 NEO MEDLIGHT, ATP 38) and HypnoVR virtual-reality sessions. A wholly-owned subsidiary, ROC37 (Recherche Oncologique Clinique 37), runs the clinical research program and holds ISO 9001 certification for clinical research coordination from Apave.

The business model is a fee-for-service healthcare provider reimbursed primarily through the French public health insurance system (Sécurité Sociale) per the national medical fee schedule for oncology and radiotherapy procedures. Patients are acquired through referrals from GPs, specialists and other oncologists across the region, and the center supplements clinical services with a network of partnerships for supportive care, including Appui Santé 37, Ligue contre le cancer – Comité 37, Oncologie 37, and Association GO – AJA. Ownership is restricted to its physician-shareholders, with no external parent, institutional investors, or public listing evidenced.

Name

Centre d'Oncologie et de Radiothérapie 37

Legal name

Société Centre d'Oncologie et de Radiothérapie 37 SESARL

Website

https://cort37.fr

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

CORT 37 is a physician-owned radiotherapy and oncology center in Chambray-lès-Tours, France, serving 1,000+ cancer patients annually with advanced radiotherapy, chemotherapy, supportive care, and clinical trials via its ROC37 subsidiary.

Ownership category

akta.pro rank

Product category

Oncology and Radiotherapy Services

NAICS

Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH)

Keywords

• Radiotherapy treatments
• Oncology services
• Cancer care center
• Brachytherapy treatments
• Supportive cancer care

Headquarters

HQ city

Chambray-lès-Tours

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Radiotherapy and Oncology Treatments: Healthcare provider revenue through the French public healthcare system (Sécurité Sociale) for radiotherapy, chemotherapy, and curietherapy treatments. Medical procedures are billed through the national health insurance system.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

CORT 37 is a private oncology and radiotherapy medical centre delivering high-precision radiotherapy treatments (external, stereotactic, contact therapy with Papillon+, IMRT/IGRT, and HDR brachytherapy with Saginova), chemotherapy, supportive care services, photobiomodulation and HypnoVR-based anxiety management, and on-site clinical research through its ISO 9001-certified ROC37 subsidiary, treating more than 1,000 patients and approximately 26,000 sessions per year in Indre-et-Loire, France.

Product overview

CORT 37 is a radiotherapy and oncology center providing a unified set of cancer treatment services, primarily radiotherapy (external, contact therapy, stereotactic, brachytherapy, IMRT/IGRT) and chemotherapy, supported by medical equipment from Varian (Halcyon, Truebeam), Bebig (Saginova), Clerad (Papillon+), and Siemens (Somatom Go.sim scanner). The center operates as a single facility with a clinical research subsidiary (ROC37) and offers supportive care services including photobiomodulation (THOR, CAREMIN 650 NEO, ATP38 devices) and HypnoVR virtual reality for pain and anxiety management. The portfolio is organized around core treatment services supported by specialized equipment and supplementary supportive care, all delivered at a single site in Chambray-lès-Tours.

Differentiator

Problem solved

Functional benefit

Products and services

• External Radiotherapy
• Contact Therapy (Contacthérapie)
• Stereotactic Radiotherapy
• IMRT and IGRT
• Brachytherapy (Curiethérapie)
• Chemotherapy
• Supportive Care (Soins de Support)
• Photobiomodulation
• HypnoVR Virtual Reality
• Clinical Research

Quantifiable outcome

• 26,000 radiotherapy sessions per year
• +1 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Seven partnerships are on record, tiered core, primary, secondary and minor.

• ROC37 (Recherche Oncologique Clinique 37)coreStrategic or Co-development PartnerClinical research subsidiary of CORT37 established after 5 years of clinical research activity. Holds ISO 9001 certification for clinical research coordination with no findings. Conducts clinical trials in various oncology indications.
• Oncologie 37primaryStrategic or Co-development PartnerPartnership for adapted physical activity (APA) services for cancer patients. Provides home-based APA sessions and sexology consultations on prescription.
• Appui Santé 37primaryStrategic or Co-development PartnerAssociation funded by ARS Centre-Val de Loire providing supportive care services for cancer patients in Indre-et-Loire. Services include psychologist, dietitian, and socio-esthetician on medical prescription with coverage.
• Association GO – AJAsecondaryStrategic or Co-development PartnerAssociation created in 2012 federating oncologists, hematologists, pediatricians and specialists supporting adolescents and young adults (AJA) with cancer. Shares experiences and supports innovative projects in AJA cancer care.
• Ligue contre le cancer – Comité 37primaryStrategic or Co-development PartnerRegional committee of Ligue contre le cancer offering support services: welcome, listening, information, well-being workshops (relaxation, aesthetics, discussion), legal and social assistance. Present in Tours, Loches, Chinon.
• Ville de Tours - Parcours Forme & Bien-ÊtreminorStrategic or Co-development PartnerCity of Tours program providing adapted physical activity for patients with chronic conditions including cancer through the Parcours santé.
• PAIPS / Sport Santé Centre-Val de LoireminorStrategic or Co-development PartnerRegional program helping patients find adapted physical activity near their location.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Institut de Cancérologie de l'Ouest (ICO): French regional cancer center operating across Nantes and Angers delivering radiotherapy, chemotherapy and supportive care to a similar oncology population. Directly comparable as a multi-site French oncology operator integrating treatment and clinical research like CORT 37.
• Centre Paul Strauss: Regional cancer center in Strasbourg offering radiotherapy, chemotherapy and clinical research. Operates a similar model of integrated radiotherapy and oncology trials within a single regional facility.
• Institut Bergonié: Comprehensive cancer center in Bordeaux offering radiotherapy, chemotherapy and clinical trials within a single facility structure. Mirrors CORT 37's combination of precision radiotherapy with on-site research and supportive services.
• Centre Léon Bérard: CLCC comprehensive cancer center in Lyon providing radiotherapy, chemotherapy and clinical research across multiple oncology indications. Comparable private-style medical-center model delivering precision radiotherapy alongside medical oncology.

Broad incumbents

• Institut Curie: Major Paris-based oncology center combining radiotherapy, medical oncology and translational research. A broad incumbent competitor for high-acuity referrals and clinical trial enrollment that CORT 37's ROC37 arm also targets.
• Ramsay Santé: Largest French private hospital group offering oncology services including chemotherapy and radiotherapy across its network. A broad incumbent that competes for the same private radiotherapy patient pool in regional markets.
• Elsan: Major French private healthcare group operating clinics with oncology and radiotherapy offerings. A broad incumbent that could expand radiotherapy capacity in CORT 37's catchment through partnerships or new sites.
• GenesisCare: International operator of radiation oncology and medical oncology centers with significant presence in Europe, including France. Comparable as a private-sector radiotherapy operator scaling precision radiotherapy services outside of public hospitals.
• Gustave Roussy: Leading European comprehensive cancer center near Paris offering full-spectrum radiotherapy, medical oncology and large-scale clinical research. A broader incumbent whose scale and trial portfolio set the upper benchmark for French oncology competition to CORT 37.

Others

• Unicancer: Federation coordinating the French network of Comprehensive Cancer Centers (CLCCs). Relevant ecosystem player because CLCC members directly compete with CORT 37 for radiotherapy referrals and clinical trial activity in the regions.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/centre.radiotherapie37
• LinkedInlinkedin.com/company/centre-d-oncologie-et-de-radioth%C3%A9rapie-c-o-r-t-37
• Instagraminstagram.com/centreoncologieradiotherapie37

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centre d'Oncologie et de Radiothérapie 37